Clinical Outcomes After Biologic Initiation in Asthma With and Without Allergic Bronchopulmonary Aspergillosis
Summary Primary matched analysis showed no statistically distinguishable excess one‐year asthma exacerbation risk with coded ABPA. Biomarker‐independent and recent‐ABPA analyses were consistent; exploratory steroid and pneumonia findings require caution.
Authors
- Adeel Nasrullah (ORCID: https://orcid.org/0000-0001-7604-6978)
- Humza Saeed (ORCID: https://orcid.org/0009-0003-0256-4272)
- Usama Shujaatullah Khan (ORCID: https://orcid.org/0009-0002-2700-9753)
- Navneet Gupta (ORCID: https://orcid.org/0009-0009-7252-3226)
- Ahmed Mahmoud (ORCID: https://orcid.org/0009-0000-7565-3864)
- Zayaan A. Adrish
- Abu Baker Sheikh (ORCID: https://orcid.org/0000-0003-0503-6961)
Institutions
- Allegheny Health Network (US)
- University of New Mexico (US)
- Rawalpindi Medical University (PK)
- Drexel University (US)
Publication Details
- Journal
- Clinical & Experimental Allergy
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1111/cea.70483
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00